Research Publications

Peer Reviewed Research Publications

  1. Brit J Oncol. 2015 (submitted). Completeness of intracranial tumour recording in the Scottish Cancer Registry, 2011-12. Morling JR, Grant R, Brewster DH.
  2. Neuro-Oncology 2015 (submitted). Epilepsy in Primary Brain Tumor Patients: Mechanisms, management and impact. Armstrong TS, Grant R, Gilbert MR, Lee JW, Norden AD.
  3. Cochrane Database Syst Rev. 2015 Dec 14;3:CD007609(updated). Patient positioning (mobilisation) and bracing for pain relief and spinal stability in metastatic spinal cord compression in adults. Lee SH, Cox KM, Grant R, Kennedy C, Kilbride L.
  4. Neuropsychiatr Dis Treat. 2015 Jun 10;11:1413-20. Psychiatric symptoms in glioma patients: from diagnosis to management.Boele FW, Rooney AG, Grant R, Klein M.
  5. Cochrane Database Syst Rev. 2014 Dec:CD006932. Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation. Day J. -------- Grant R, J Li, Brown P.
  6. Pain. 2014 Sep 23. pii: S0304-3959(14)00443-6. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis.Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin L, Fallon M
  7. Cochrane Database Syst Rev. 2014 Sep 22;9:CD008218.Antiangiogenic therapy for high-grade glioma. Khasraw M, Ameratunga MS, Grant R, Wheeler H, Pavlakis N.
  8. J Neurooncol. 2014 Aug 24. [Epub ahead of print] Symptoms and medication management in the end of life phase of high-grade glioma patients. Koekkoek JA, Dirven L, Sizoo EM, Pasman HR, Heimans JJ, Postma TJ, Deliens L, Grant R, McNamara S, Stockhammer G, Medicus E, Taphoorn MJ, Reijneveld JC.
  9. J Neurooncol. 2014 Nov;120(2):303-10. doi: 10.1007/s11060-014-1548-5. Epub 2014 Jul 20. End of life care in high-grade glioma patients in three European countries: a comparative study. Koekkoek JA, Dirven L, Reijneveld JC, Sizoo EM, Pasman HR, Postma TJ, Deliens L, Grant R, McNamara S, Grisold W, Medicus E, Stockhammer G, Oberndorfer S, Flechl B, Marosi C, Taphoorn MJ, Heimans JJ.
  10. Neurology. 2014 Aug 5;83(6):537-41 Mental incapacity in patients undergoing neuro-oncologic treatment: a cross-sectional study. Kerrigan S, Erridge S, Liaquat I, Graham C, Grant R.
  11. Support Care Cancer. 2014 Mar;22(3):847-57 The end-of-life phase of high-grade glioma patients: a systematic review. Sizoo EM, Pasman HR, Dirven L, Marosi C, Grisold W, Stockhammer G, Egeter J, Grant R, Chang S, Heimans JJ, Deliens L, Reijneveld JC, Taphoorn MJ.
  12. Support Care Cancer. 2014 Apr;22(4):1059-69. Assessment of a brain-tumour-specific Patient Concerns Inventory in the neuro-oncology clinic. Rooney AG, Netten A, McNamara S, Erridge S, Peoples S, Whittle I, Hacking B, Grant R.
  13. Neuro-Oncol Prac 2014; 1(3): 123-133. Gallagher P, leach JP, Grant R. Time to focus on brain tumor related epilepsy trials.
  14. Neuro-Oncol Prac 2014; 1(3): 134-40. Epilepsy in the end of life phase of brain tumor patients: a systematic review. Koekkoek JAF, Dirven L, Reijneveld JC, Postma TJ, Grant R , Pace A et al.
  15. J Neurol Neurosurg Psychiatry. 2014 Feb;85(2):230-5. Depression in glioma: a primer for clinicians and researchers. Rooney AG, Brown PD, Reijneveld JC, Grant R.
  16. Cochrane Database Syst Rev. 2013 May 31;5:CD006932. Pharmacological treatment of depression in patients with a primary brain tumour. Rooney A, Grant R.
  17. Eur J Cancer. 2013 Sep;49(13):2910-8. Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS). Binda D, Vanhoutte EK, Cavaletti G, Cornblath DR, Postma TJ, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galiè E, Briani C, Dalla Torre C, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Rossi E, Valsecchi MG, Faber CG, Merkies IS; CI-PeriNomS study group, Galimberti S, Lanzani F, Mattavelli L, Piatti ML, Bidoli P, Cazzaniga M, Cortinovis D, Lucchetta M, Campagnolo M, Bakkers M, Brouwer B, Boogerd W, Grant R, Reni L, Piras B, Pessino A, Padua L, Granata G, Leandri M, Ghignotti I, Plasmati R, Pastorelli F, Heimans JJ, Eurelings M, Meijer RJ, Grisold W, Lindeck Pozza E, Mazzeo A, Toscano A, Russo M, Tomasello C, Altavilla G, Penas Prado M, Dominguez Gonzalez C, Dorsey SG.
  18. Cochrane Database Syst Rev. 2013 Apr 30;4:CD007415 Temozolomide for high grade glioma. Hart MG, Garside R, Rogers G, Stein K, Grant R.
  19. Neurooncology 2013 Mar (vol 3). The frequency, longitudinal course, clinical associations, and causes of emotional distress during primary treatment of cerebral glioma Rooney, AG, McNamara S, MacKinnon M, Fraser M, Rampling R, Carson A, Grant R
  20. J Neurooncol 2013 Mar (on line). Screening for major depressive disorcer in adults with glioma using the PHQ-9: a comparison of patient versus proxy reports. Rooney, AR, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, Grant R.
  21. Neurooncol 2012 Dec. Screening for Major depressive disorder in adults with cerebral glioma: an initial validation of three self report instruments. Rooney A, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, Grant R.
  22. Pract Neurol. 2012 Apr;12(2):116-25. Encephalopathy in a 45-year-old woman. Derry C, Allen C, Grant R et al.
  23. Pract Neurol. 2012 Apr;12(2):72-6. Low-grade brain tumours and seizures. Kerrigan S, Grant R.
  24. Am J Clin Oncol. 2012 Feb;35(1):100. SSRIs may (or may not) be a safe treatment for depression in GBM. Rooney A, Grant R.
  25. Handb Clin Neurol. 2012;104:371-9. Steroids and brain tumors. Hart MG, Whittle IR, Grant R.
  26. J Clin Oncol. 2011 Nov 10;29(32):4307-12. Epub 2011 Oct 11. Frequency, clinical associations, and longitudinal course of major depressive disorder in adults with cerebral glioma. Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, Grant R.
  27. Cochrane Database Syst Rev. 2011 Aug 10;(8):CD008586. Antiepileptic drugs for treating seizures in adults with brain tumours. Kerrigan S, Grant R.
  28. Br J Neurosurg. 2012 Feb;26(1):28-31. Epub 2011 Aug 4. Recognition of mental incapacity when consenting patients with intracranial tumours for surgery: how well are we doing? Kerrigan S, Dengu F, Erridge S, Grant R, Whittle IR.
  29. Cochrane Database Syst Rev. 2011 Mar 16;(3):CD007294. Chemotherapy wafers for high grade glioma. Hart MG, Grant R, Garside R, Rogers G, Somerville M, Stein K.
  30. Neurooncol. 2011 Sep;104(3):789-800. Epub 2011 Mar 8. Trends in classification, referral and treatment and the effect on outcome of patients with glioma: a 20 year cohort. Erridge SC, Hart MG, Kerr GR, Smith C, McNamara S, Grant R, Gregor A, Whittle IR.
  31. J Natl Cancer Inst. 2011 Jan 5;103(1):61-76. Epub 2010 Nov 24. Depression in cerebral glioma patients: a systematic review of observational studies. Rooney AG, Carson A, Grant R.
  32. J Clin Nurs. 2010 Jul;19(13-14):1767-83. Metastatic spinal cord compression: a review of practice and care. Kilbride L, Cox M, Kennedy CM, Lee SH, Grant R.
  33. Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, Frénay M, Grisold W, Grant R, Graus F, Hoang-Xuan K, Klein M, Melin B, Rees J, Siegal T, Smits A, Stupp R, Wick W; European Federation of Neurological Societies. Eur J Neurol. 2010 Sep;17(9):1124-33.
  34. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006932. Pharmacological treatment of depression in patients with a primary brain tumour. Rooney A, Grant R.
  35. Radiother Oncol. 2009 Dec;93(3):597-601. Radiotherapy for pituitary adenomas: long-term efficacy and toxicity. Erridge SC, Conkey DS, Stockton D, Strachan MW, Statham PF, Whittle IR, Grant R, Kerr GR, Gregor A.
  36. J Neurooncol. 2009 Dec;95(3):449. Female gender is not a proven risk factor for depression in glioma. Rooney AG, van Nieuwenhuizen D, Reijneveld JC, Grant R.
  37. Mov Disord. 2009 Sep 15;24(12):1715-24. Paraneoplastic movement disorders. Grant R, Graus F.
  38. BMJ Case Rep. 2009. pii: bcr09.2008.0875. Epub 2009 Feb 2. Stroke due to a cardiac myxoma. Al-Shahi Salman R, Northridge D, Graham AN, Grant R.
  39. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD007415. Temozolomide for high grade glioma. Hart MG, Grant R, Garside R, Rogers G, Somerville M, Stein K.
  40. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD007294. Chemotherapeutic wafers for High Grade Glioma. Hart MG, Grant R, Garside R, Rogers G, Somerville M, Stein K.
  41. Br J Neurosurg. 2008 Jun;22(3):339-49. Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years? Anderson E, Grant R, Lewis SC, Whittle IR.
  42. J Neurooncol. 2007 Sep;84(3):297-304. Epub 2007 Jun 27. The frequency and cause of anxiety and depression amongst patients with malignant brain tumours between surgery and radiotherapy. Kilbride L, Smith G, Grant R.
  43. Pract Neurol. 2007 Feb;7(1):52-5. Stroke due to a cardiac myxoma. Al-Shahi Salman R, Northridge D, Graham AN, Grant R.
  44. Eur J Neurol. 2006 Jul;13(7):674-81. EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Soffietti R, Cornu P, Delattre JY, Grant R, Graus F, Grisold W, Heimans J, Hildebrand J, Hoskin P, Kalljo M, Krauseneck P, Marosi C, Siegal T, Vecht C.
  45. Clin Oncol (R Coll Radiol). 2006 Mar;18(2):104-8. A pilot study of brain tumour growth between radiotherapy planning and delivery. Pennington C, Kilbride L, Grant R, Wardlaw JM.
  46. Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003292. Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastases. Hart MG, Grant R, Walker M, Dickinson H.
  47. J Neurol Neurosurg Psychiatry. 2004 Jun;75 Suppl 2:ii18-23. Overview: Brain tumour diagnosis and management/Royal College of Physicians guidelines. Grant R.
  48. Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma. Walker M, Brown J, Brown K, Gregor A, Whittle IR, Grant R. J Neurooncol. 2003 Jun;63(2):179-86.
  49. How well do radiologists diagnose intracerebral tumour histology on CT? Findings from a prospective multicentre study. Bell D, Grant R, Collie D, Walker M, Whittle IR. Br J Neurosurg. 2002 Dec;16(6):573-7.
  50. Don't wait for a sensory level--listen to the symptoms: a prospective audit of the delays in diagnosis of malignant cord compression. Levack P, Graham J, Collie D, Grant R, Kidd J, Kunkler I, Gibson A, Hurman D, McMillan N, Rampling R, Slider L, Statham P, Summers D; Scottish Cord Compression Study Group. Clin Oncol (R Coll Radiol). 2002 Dec;14(6):472-80.
  51. Management of patients aged >60 years with malignant glioma: good clinical status and radiotherapy determine outcome. Whittle IR, Basu N, Grant R, Walker M, Gregor A. Br J Neurosurg. 2002 Aug;16(4):343-7
  52. Imaging response to chemotherapy with RMP-7 and carboplatin in malignant glioma: size matters but speed does not. Grant R, Walker M, Hadley D, Barton T, Osborn C. J Neurooncol. 2002 May;57(3):241-5.
  53. Dilemmas in cancer care. Kunkler I, Grant R, Collie D, Levack P. Lancet Oncol. 2000 Dec;1:204
  54. Biopsy versus resection for malignant glioma. Metcalfe SE, Grant R. Cochrane Database Syst Rev. 2001;(3):CD002034. Review.
  55. Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy. Grant R, Shorvon SD. Epilepsy Res. 2000 Dec;42(2-3):89-95.
  56. Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high grade glioma. RMP-7 European Study Group. Gregor A, Lind M, Newman H, Grant R, Hadley DM, Barton T, Osborn C. J Neurooncol. 1999 Sep;44(2):137-45.
  57. Imaging features of leptomeningeal metastases. Collie DA, Brush JP, Lammie GA, Grant R, Kunkler I, Leonard R, Gregor A, Sellar RJ. Clin Radiol. 1999 Nov;54(11):765-71.
  58. Use of different outcome measures in randomised studies of malignant glioma can significantly alter the interpretation of time to progression: reanalysis of the MRC BR2 study. Chataway J, Stenning S, Bleehen N, Grant R. J Neurooncol. 1999 May;43(1):87-92.
  59. Mobiles on the brain Grant R. BMJ. 1999 May 29;318(7196):1495.
  60. Significant change in tests of neurological impairment in patients with brain tumours. Clyde Z, Chataway SJ, Signorini D, Gregor A, Grant R. J Neurooncol. 1998 Aug;39(1):81-90.
  61. Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial. Latif AZ, Signorini D, Gregor A, Grant R, Ironside JW, Whittle IR. J Neurol Neurosurg Psychiatry. 1998 Jun;64(6):747-50.
  62. Incidence studies of primary and secondary intracranial tumors: a systematic review of their methodology and results. Counsell CE, Grant R. J Neurooncol. 1998 May;37(3):241-50. Review
  63. Neurological paraneoplastic syndromes. Nath U, Grant R. J Clin Pathol. 1997 Dec;50(12):975-80. Review.
  64. Limitations of using a cancer registry to identify incident primary intracranial tumours. Counsell CE, Collie DA, Grant R. J Neurol Neurosurg Psychiatry. 1997 Jul;63(1):94-7.
  65. Chemotherapy response criteria in malignant glioma. Grant R, Liang BC, Slattery J, Greenberg HS, Junck L. Neurology. 1997 May;48(5):1336-40.
  66. Incidence of intracranial tumours in the Lothian region of Scotland, 1989-90. Counsell CE, Collie DA, Grant R. J Neurol Neurosurg Psychiatry. 1996 Aug;61(2):143-50.
  67. Referral pattern and management of patients with malignant brain tumours in south east Scotland. Grant R, Whittle IR, Collie DA, Gregor A, Ironside JW. Health Bull (Edinb). 1996 May;54(3):212-22.
  68. Cerebral vasculitis following allopurinol treatment. Rothwell PM, Grant R. Postgrad Med J. 1996 Feb;72(844):119-20.
  69. The incidence of cerebral glioma in the working population: a forgotten cancer? Grant R, Collie D, Counsell C. Br J Cancer. 1996 Jan;73(2):252-4.
  70. Age influences chemotherapy response in astrocytomas. Grant R, Liang BC, Page MA, Crane DL, Greenberg HS, Junck L. Neurology. 1995 May;45(5):929-33.
  71. Analysis of the pharyngoesophageal pressure profile in amyotrophic lateral sclerosis. MacDougall G, Wilson JA, Pryde A, Grant R. Otolaryngol Head Neck Surg. 1995 Feb;112(2):258-61.
  72. The effect of tumour associated epilepsy on performance/handicap scales used in cerebral glioma. Macleod M, Slattery J, Grant R. Br J Neurosurg. 1995;9(5):653-7.
  73. Glutathione S-transferases and cytochrome P450 detoxifying enzyme distribution in human cerebral glioma. Grant R, Ironside JW. J Neurooncol. 1995;25(1):1-7.
  74. Pure alexia without agraphia: a classical cortical syndrome revisited. Duffield JS, de Silva RN, Grant R. Scott Med J. 1994 Dec;39(6):178-9.
  75. Reversal of subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin. Counsell CE, McLeod M, Grant R. Neurology. 1994 Jun;44(6):1184-5.
  76. Clinical outcome in aggressively treated meningeal carcinomatosis. Grant R, Naylor B, Greenberg HS, Junck L. Arch Neurol. 1994 May;51(5):457-61
  77. Metastatic epidural spinal cord compression: current concepts and treatment. Grant R, Papadopoulos SM, Sandler HM, Greenberg HS. J Neurooncol. 1994;19(1):79-92. Review
  78. Recording neurological impairment in clinical trials of glioma. Grant R, Slattery J, Gregor A, Whittle IR. J Neurooncol. 1994;19(1):37-49.
  79. Primary central-nervous-system lymphoma - treatment with multiagent systemic and intrathecal chemotherapy with radiation-therapy. Liang B, Grant R, Junck L, Sandler H, Papadopoulos S, Kaminski M, Greenberg H. Int J Oncol. 1993 Nov;3(5):1001-4.
  80. Cerebral venous sinus thrombosis induced by 'ecstasy'. Rothwell PM, Grant R. J Neurol Neurosurg Psychiatry. 1993 Sep;56(9):1035
  81. Clinical outcome in aggressively treated meningeal gliomatosis. Grant R, Naylor B, Junck L, Greenberg HS. Neurology. 1992 Jan;42(1):252-4.
  82. Metastatic epidural spinal cord compression. Grant R, Papadopoulos SM, Greenberg HS. Neurol Clin. 1991 Nov;9(4):825-41. Review.
  83. Severe amnesia after hypoglycemia. Clinical, psychometric, and magnetic resonance imaging correlations. Chalmers J, Risk MT, Kean DM, Grant R, Ashworth B, Campbell IW. Diabetes Care. 1991 Oct;14(10):922-5.
  84. Changes in intracranial CSF volume after lumbar puncture and their relationship to post-LP headache. Grant R, Condon B, Hart I, Teasdale GM. J Neurol Neurosurg Psychiatry. 1991 May;54(5):440-2.
  85. The effect of chorda tympani section on ipsilateral and contralateral salivary secretion and taste in man. Grant R, Miller S, Simpson D, Lamey PJ, Bone I. J Neurol Neurosurg Psychiatry. 1989 Sep;52(9):1058-62.
  86. Comparison of magnetic resonance imaging and computed tomography in suspected lesions in the posterior cranial fossa. Teasdale GM, Hadley DM, Lawrence A, Bone I, Burton H, Grant R, Condon B, Macpherson P, Rowan J. BMJ. 1989 Aug 5;299(6695):349-55.
  87. Changes in cranial CSF volume during hypercapnia and hypocapnia. Grant R, Condon B, Patterson J, Wyper DJ, Hadley MD, Teasdale GM. J Neurol Neurosurg Psychiatry. 1989 Feb;52(2):218-22.
  88. Brain and intracranial cavity volumes: in vivo determination by MRI. Condon B, Grant R, Hadley D, Lawrence A. Acta Neurol Scand. 1988 Nov;78(5):387-93.
  89. Temporal physiochemical changes during in vitro relaxation time measurements: the cerebrospinal fluid. Grant R, Condon B, Moyns S, Patterson J, Hadley D, Teasdale G. Magn Reson Med. 1988 Apr;6(4):397-402.
  90. Quantifying intracranial CSF volume using MRI. Condon BR, Wyper DJ, Patterson J, Grant R. J Nucl Med. 1988 Jan;29(1):132-3.
  91. Is cranial CSF volume under hormonal influence? An MR study. Grant R, Condon B, Lawrence A, Hadley DM, Patterson J, Bone I, Teasdale GM. J Comput Assist Tomogr. 1988 Jan-Feb;12(1):36-9.
  92. Intracranial CSF volumes: natural variations and physiological changes measured by MRI. Teasdale GM, Grant R, Condon B, Patterson J, Lawrence A, Hadley DM, Wyper D. Acta Neurochir Suppl (Wien). 1988;42:230-5.
  93. MRI measurement of syrinx size before and after operation. Grant R, Hadley DM, Lang D, Condon B, Johnston R, Bone I, Teasdale GM. J Neurol Neurosurg Psychiatry. 1987 Dec;50(12):1685-7.
  94. Magnetic resonance imaging in the management of resistant focal epilepsy: pathological case report and experience of 12 cases. Grant R, Hadley DM, Condon B, Doyle D, Patterson J, Bone I, Galbraith SL, Teasdale GM. J Neurol Neurosurg Psychiatry. 1987 Nov;50(11):1529-32.
  95. Severe myotonia relieved by nifedipine. Grant R, Weir AI. Ann Neurol. 1987 Sep;22(3):395.
  96. Syringomyelia: cyst measurement by magnetic resonance imaging and comparison with symptoms, signs and disability. Grant R, Hadley DM, Macpherson P, Condon B, Patterson J, Bone I, Teasdale GN. J Neurol Neurosurg Psychiatry. 1987 Aug;50(8):1008-14.
  97. Magnetic resonance imaging and smooth periventricular high-signal areas. Grant R, Hadley DM, Graham DI, Condon B, Teasdale GM. Lancet. 1987 Apr 4;1(8536):807-8.
  98. The neurological assault on the great toe (1893-1911). Grant R. Scott Med J. 1987 Apr;32(2):57-9.
  99. MR relaxation times of cerebrospinal fluid. Condon B, Patterson J, Jenkins A, Wyper D, Hadley D, Grant R, Rowan J, Teasdale G. J Comput Assist Tomogr. 1987 Mar-Apr;11(2):203-7.
  100. Nifedipine in the treatment of myotonia in myotonic dystrophy. Grant R, Sutton DL, Behan PO, Ballantyne JP. J Neurol Neurosurg Psychiatry. 1987 Feb;50(2):199-206
  101. Evoked taste thresholds in a normal population and the application of electrogustometry to trigeminal nerve disease. Grant R, Ferguson MM, Strang R, Turner JW, Bone I. J Neurol Neurosurg Psychiatry. 1987 Jan;50(1):12-21
  102. Human cranial CSF volumes measured by MRI: sex and age influences. Grant R, Condon B, Lawrence A, Hadley DM, Patterson J, Bone I, Teasdale GM. Magn Reson Imaging. 1987;5(6):465-8.
  103. Normal pressure hydrocephalus. Hadley DM, Grant R, Condon B.Br Med J (Clin Res Ed). 1986 Nov 1;293(6555):1173-4.
  104. A quantitative index of ventricular and extraventricular intracranial CSF volumes using MR imaging. Condon BR, Patterson J, Wyper D, Hadley DM, Teasdale G, Grant R, Jenkins A, Macpherson P, Rowan J. J Comput Assist Tomogr. 1986 Sep-Oct;10(5):784-92.
  105. Backache and the Guillain-Barre syndrome. Grant R. Br Med J (Clin Res Ed). 1986 Aug 23;293(6545):506.
  106. Use of magnetic resonance imaging to measure intracranial cerebrospinal fluid volume. Condon B, Patterson J, Wyper D, Hadley D, Grant R, Teasdale G, Rowan J. Lancet. 1986 Jun 14;1(8494):1355-7.
  107. Unsuccessful treatment of Creutzfeldt-Jakob disease with acyclovir. David AS, Grant R, Ballantyne JP.Lancet. 1984 Mar 3;1(8375):512-3.

Book Chapters

  • Behan PO, Behan WHM, Grant R.  Immunological aspects of myotonic dystrophy.  In: Clinical Immunology 1987; Blackwell Publishing Co
  • Grant R, Papadopoulos S, Greenberg HS.  Metastatic epidural spinal cord compression.  In: Neurologic Clinics of North America 1991; W B Saunders.Co.
  • Grant R, Harris E.  Paediatric Neurology.  In: Paediatrics for Chiropodists (Podiatrists) 1992; Bailliere Tindall Limited
  • Grant R, Papadopoulos S, Sandler H, Greenberg HS.  Metastatic epidural spinal cord compression.  In:Principles and Practice of Neurocritical Care.  Williams and Wilkens Pubs. 1994.
  • R Grant. Chapter 18; Tumours of the Brain and Skull and Chapter 19 Neurocutaneous Syndromes. In Brain’s Diseases of the Nervous System 11th Edition. Ed. Donaghy. Oxford Press 2001
  • Hart M, Grant R. The Lancet Handbook of Treatment in Neurology  19. Tumours and Paraneoplastic Syndromes. 2006.
  • Whiteley W, Grant R. Chapter 100. Neurological Complication of Treatments. In Neurology and Clinical Neurosciences.   Ed. Shapira et al. 2008
  • Hart M, Grant R Neuro-Oncology – Neurological Complications of Cancer (Elsevier (2009)
  • Grant R. Brains Textbook of Neurology 12th edition (2012). Chapters: (a) Imaging of the Nervous System (b) Neurocutaneous syndromes (c) Tumours of the Brain and Skull
  • Hart MG, Grant R, Whittle IR. Handbook of Clinical Neurology, 3rd edition: Steroids and Brain Tumours. (2009)
  • Grant R, Graus F. Paraneoplastic Movement Disorders. Movement Disorders 2009; 24 (12): 1715-24.
  • Grant R. Medical complications in the management of Brain Tumours. Chapt 12. Elsevier 2012
  • Grant R. Intracranial and Intraspinal Lipomas. In Neurobase. Arbor Pubs, La Jolla, California 2015.
  • Grant R. Oligodendrogliomas and Oligoastrocytomas. In Neurobase. Arbor Pubs, La Jolla, California 2014.
  • Grant R. Dermoid and Epidermoid Tumors. In Neurobase. Arbor Pubs, La Jolla, California 2015.
  • Grant R. Arachnoid Cysts. In Neurobase. Arbor Pubs, La Jolla, California 2015.